These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 17891441)
41. [Interest of sentinel lymph node biopsy for the staging of ductal carcinoma in situ]. Buttarelli M; Houvenaeghel G; Martino M; Rossi I; Ronda I; Ternier F; Tallet A; Jacquemier J Ann Chir; 2004 Nov; 129(9):508-12. PubMed ID: 15556580 [TBL] [Abstract][Full Text] [Related]
42. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology. Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108 [TBL] [Abstract][Full Text] [Related]
43. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492 [TBL] [Abstract][Full Text] [Related]
44. [Importance of sentinel lymph node biopsy in surgical therapy of in situ breast cancer]. Takács T; Szentpáli K; Paszt A; Ormándi K; Lázár M; Pálka I; Kahán Z; Lázár G Magy Onkol; 2006; 50(3):247-51. PubMed ID: 17099786 [TBL] [Abstract][Full Text] [Related]
45. Optimal management of ductal carcinoma in situ of the breast. Sakorafas GH; Farley DR Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563 [TBL] [Abstract][Full Text] [Related]
46. Axillary recurrence in DCIs: is axillary lymphadenectomy warranted? Trisal V; Qian D; Wagman LD Am Surg; 2004 Oct; 70(10):876-80. PubMed ID: 15529841 [TBL] [Abstract][Full Text] [Related]
47. Results of 23,810 cases of ductal carcinoma-in-situ. Sumner WE; Koniaris LG; Snell SE; Spector S; Powell J; Avisar E; Moffat F; Livingstone AS; Franceschi D Ann Surg Oncol; 2007 May; 14(5):1638-43. PubMed ID: 17245612 [TBL] [Abstract][Full Text] [Related]
48. Feasibility of sentinel lymph node biopsy through an inframammary incision for a nipple-sparing mastectomy. Kiluk JV; Santillan AA; Kaur P; Laronga C; Meade T; Ramos D; Cox CE Ann Surg Oncol; 2008 Dec; 15(12):3402-6. PubMed ID: 18820974 [TBL] [Abstract][Full Text] [Related]
49. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important. Jones JL; Zabicki K; Christian RL; Gadd MA; Hughes KS; Lesnikoski BA; Rhei E; Specht MC; Dominguez FJ; Smith BL Am J Surg; 2005 Oct; 190(4):517-20. PubMed ID: 16164912 [TBL] [Abstract][Full Text] [Related]
50. The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study. Tunon-de-Lara C; Chauvet MP; Baranzelli MC; Baron M; Piquenot J; Le-Bouédec G; Penault-Llorca F; Garbay JR; Blanchot J; Mollard J; Maisongrosse V; Mathoulin-Pélissier S; MacGrogan G Ann Surg Oncol; 2015 Nov; 22(12):3853-60. PubMed ID: 25777085 [TBL] [Abstract][Full Text] [Related]
51. Sentinel node biopsy alone for node-positive breast cancer: 12-year experience at a single institution. Spiguel L; Yao K; Winchester DJ; Gorchow A; Du H; Sener SF; Martz B; Turk M; Barrera E; Winchester DP J Am Coll Surg; 2011 Jul; 213(1):122-8; discussion 128-9. PubMed ID: 21530326 [TBL] [Abstract][Full Text] [Related]
52. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Wilkie C; White L; Dupont E; Cantor A; Cox CE Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920 [TBL] [Abstract][Full Text] [Related]
53. Detecting occult malignancy in prophylactic mastectomy: preoperative MRI versus sentinel lymph node biopsy. Black D; Specht M; Lee JM; Dominguez F; Gadd M; Hughes K; Rafferty E; Smith B Ann Surg Oncol; 2007 Sep; 14(9):2477-84. PubMed ID: 17587091 [TBL] [Abstract][Full Text] [Related]
54. The role of sentinel lymph node biopsy in ductal carcinoma in situ. Moran CJ; Kell MR; Kerin MJ Eur J Surg Oncol; 2005 Dec; 31(10):1105-11. PubMed ID: 16084681 [TBL] [Abstract][Full Text] [Related]
55. Sentinel lymph node biopsy in the management of ductal carcinoma in situ. Zujewski J; Eng-Wong J Clin Breast Cancer; 2005 Aug; 6(3):216-22. PubMed ID: 16137431 [TBL] [Abstract][Full Text] [Related]
56. Surgical treatment in Paget's disease of the breast. Siponen E; Hukkinen K; Heikkilä P; Joensuu H; Leidenius M Am J Surg; 2010 Aug; 200(2):241-6. PubMed ID: 20678619 [TBL] [Abstract][Full Text] [Related]
57. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ. Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180 [TBL] [Abstract][Full Text] [Related]
58. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy. King TA; Ganaraj A; Fey JV; Tan LK; Hudis C; Norton L; Cody HS; Borgen PI Cancer; 2004 Sep; 101(5):926-33. PubMed ID: 15329899 [TBL] [Abstract][Full Text] [Related]
59. Biology and treatment of ductal carcinoma in situ. Irvine T; Fentiman IS Expert Rev Anticancer Ther; 2007 Feb; 7(2):135-45. PubMed ID: 17288525 [TBL] [Abstract][Full Text] [Related]
60. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community. Davit FE; Gatmaitan P; Garguilo G Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]